규제 업데이트2026년 8월 24일•1분 읽기

FDA Recalls Product Due to CGMP Deviations

작성: PharmaCountry 팀

The FDA has initiated a recall of a product because of deviations from current Good Manufacturing Practices (CGMP).

The U.S. Food and Drug Administration (FDA) has issued a recall for a pharmaceutical product after identifying deviations from current Good Manufacturing Practices (CGMP). The recall underscores the agency's focus on ensuring manufacturing compliance and product safety.

PharmaCountry 팀이 정리했습니다 · 출처: FDA.gov

주제:#FDA #recall #CGMP #regulatory #pharmaceuticals